On June 13th, Gelonhui reported that Yirui Biotechnology (300942.SZ) announced that the controlling shareholder and actual controller's concerted action person, Shenzhen Yidara Management Consulting Partnership Enterprise (Limited Partnership) (hereinafter referred to as 'Yidara') and Shenzhen Yikai Management Consulting Partnership Enterprise (Limited Partnership) (hereinafter referred to as 'Yikai') plan to reduce the company's shares by centralized bidding or bulk trading within three months (from July 5, 2024 to October 4, 2024), 15 trading days after the announcement. The specific situation is as follows:
1. Yidara, who holds 19,762,903 shares of the company (4.93% of the total share capital), plans to reduce its total holdings of the company's shares by centralized bidding or bulk trading not exceeding 343,739 shares (0.0857% of the total share capital).
2. Yikai, who holds 23,544,903 shares of the company (5.87% of the total share capital), plans to reduce its holdings of the company's shares by centralized bidding or bulk trading not exceeding 392,078 shares (0.0978% of the total share capital).
3. The total reduction does not exceed 735,817 shares (0.1836% of the total share capital). Among them, the number of stocks reduced by centralized bidding trading does not exceed 1% of the total share capital within any consecutive 90 natural days; the number of stocks reduced by bulk trading does not exceed 2% of the total share capital within any consecutive 90 natural days.